1. Acute myocardial infarction
Conditions
Interventions
Sponsors
Dr. S.H. Hofma
Medisch centrum Leeuwarden
cardiologie poli 67
Henri Dunantweg 2
8934 AD Leeuwarden
The Netherlands
shhofma@hetnet.nl
+31-58 2867766
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with acute ST elevated myocardial infarction; 2. Patient is willing to perform all follow-up examination as required by the protocol; 3. Patient is eligible for coronary revascularization intervention by PCI and stenting; 4. Patient is located in a geographic area that will enable contact by study site follow-up.
Exclusion criteria
Exclusion criteria: 1. Chronical total occlusion as target lesion intervention; 2. stent thrombosis or previous stent at target lesion; 3. drug,-alcohol abusers or prisoners; 4. allergic to everolimus or sirolimus; 5. intolerance or contra-indicated to treatment with acetylsalicylic acid or clopidogrel; 6. over 80 years old; 7. stent implantation not possible, judged by cardiologist; 8. intubated patients; 9. life expectancy 3.5 mm required to treat lesion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical MACE at 1 year (cardiac mortality, non-fatal myocardial infarction, TVR. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. (Sub)-acute stent thrombosis (SAT) at 30 days and late stent thrombosis (LST) at 1, 2 and 3 year; 2. Clinical MACE at 30 days and 2 and 3 year (cardiac death, non fatal MI, TVR); 3. All cause mortality at 1,2 and 3 year. | — |
Contacts
Public ContactJ. Klijn
Diagram B.V. Zwolle Dokter Stolteweg 96
Outcome results
None listed